Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Year to date metric has recorded a gain of 14.33%.However, over the last six months, we can see a weaker performance of 9.52%. Over the last 30 days, the price of BSX has fallen by 2.80%. And in the last five days, it has fallen by -1.80%.
At present, Boston Scientific Corporation (BSX) has a stock price of $52.90. In the previous session, the stock saw a rise, peaking at $53.23 after an opening price of $52.99. The day’s lowest price was $52.475, and it closed at $52.92.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Boston Scientific Corporation experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $54.99 on 08/30/23, while the lowest price for the same period was registered at $37.74 on 09/27/22.
52-week price history of BSX Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Boston Scientific Corporation’s current trading price is -3.80% away from its 52-week high, while its distance from the 52-week low is 40.15%. The stock’s price range during this period has varied between$37.74 and $54.99. The Boston Scientific Corporation’s shares, which operate in the Healthcare, saw a trading volume of around 14.52 million for the day, a figure considerably higher than their average daily volume of 7.07 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Boston Scientific Corporation (BSX) has experienced a quarterly decline of -2.00% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 77.49B and boasts a workforce of 45000 employees.
Boston Scientific Corporation: Analysts’ Ratings Unveiled
As of right now, 23 analysts are rating Boston Scientific Corporation as a BUY, 6 of the polled analysts branded the stock as an OVERWEIGHT, 4 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 52.42, with a change in price of +1.56. Similarly, Boston Scientific Corporation recorded 7,931,809 in trading volume during the last 100 days, posting a change of +3.04%.
BSX’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for BSX stands at 0.50. Similarly, the long-term debt-to-equity ratio is also 0.47.
BSX Stock Stochastic Average
Boston Scientific Corporation’s raw stochastic average for the past 50 days is presently 60.57%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 57.95%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 60.09% and 66.09%, respectively.
